G(M3) Ganglioside

G(M3) Ganglioside is a lipid of Sphingolipids (SP) class. G(m3) ganglioside is associated with abnormalities such as Metabolic Diseases, Nodular glomerulosclerosis, Renal glomerular disease, Diabetes Mellitus and Hyperglycemia. The involved functions are known as Drug Interactions, Signal Transduction, Down-Regulation, Detergents and Ligand Binding. G(m3) ganglioside often locates in Tissue membrane, Body tissue, Cell surface, Membrane and Extracellular Matrix. The associated genes with G(M3) Ganglioside are PTPN11 gene, anti-IgM, Homologous Gene, SCAP2 gene and N-dodecyl-L-lysine amide. The related lipids are de-N-acetylneuraminyllactosylceramide, Membrane Lipids, Sphingolipids, stearic acid and sialogangliosides.

Cross Reference

Introduction

To understand associated biological information of G(M3) Ganglioside, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with G(M3) Ganglioside?

G(M3) Ganglioside is suspected in Renal glomerular disease, Sandhoff Disease, Nodular glomerulosclerosis, Diabetic Nephropathy, Diabetes, Fatty Streak, Arterial and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with G(M3) Ganglioside

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with G(M3) Ganglioside?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with G(M3) Ganglioside?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with G(M3) Ganglioside?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with G(M3) Ganglioside?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with G(M3) Ganglioside?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with G(M3) Ganglioside

Download all related citations
Per page 10 20 50 100 | Total 773
Authors Title Published Journal PubMed Link
Zheng C et al. Chemoenzymatically synthesized GM3 analogues as potential therapeutic agents to recover nervous functionality after injury by inducing neurite outgrowth. 2018 Eur J Med Chem pmid:29407985
Bousquet PA et al. Hypothesis: Hypoxia induces de novo synthesis of NeuGc gangliosides in humans through CMAH domain substitute. 2018 Biochem. Biophys. Res. Commun. pmid:29196263
Wegener H et al. Human norovirus GII.4(MI001) P dimer binds fucosylated and sialylated carbohydrates. 2017 Glycobiology pmid:28973640
Komura N et al. Syntheses of Fluorescent Gangliosides for the Studies of Raft Domains. 2017 Meth. Enzymol. pmid:28935104
Valdes-Zayas A et al. Immunologic Response Elicited in Breast Cancer Patients Receiving a NeuGcGM3-based Vaccine as Adjuvant Therapy. 2017 J. Immunother. pmid:28604556
Park HJ et al. Ganglioside GM3 induces cumulus cell apoptosis through inhibition of epidermal growth factor receptor-mediated PI3K/AKT signaling pathways during in vitro maturation of pig oocytes. 2017 Mol. Reprod. Dev. pmid:28585705
Dufresne M et al. Multimodal detection of GM2 and GM3 lipid species in the brain of mucopolysaccharidosis type II mouse by serial imaging mass spectrometry and immunohistochemistry. 2017 Anal Bioanal Chem pmid:27873002
Han YB et al. Structural Insights into the Broad Substrate Specificity of a Novel Endoglycoceramidase I Belonging to a New Subfamily of GH5 Glycosidases. 2017 J. Biol. Chem. pmid:28179425
Choi H et al. Monosialyl Ganglioside GM3 Decreases Apolipoprotein B-100 Secretion in Liver Cells. 2017 J. Cell. Biochem. pmid:28019668
Suzuki KGN et al. Development of new ganglioside probes and unraveling of raft domain structure by single-molecule imaging. 2017 Biochim. Biophys. Acta pmid:28734966
Trilck M et al. Diversity of glycosphingolipid GM2 and cholesterol accumulation in NPC1 patient-specific iPSC-derived neurons. 2017 Brain Res. pmid:27923633
Go S et al. Altered expression of ganglioside GM3 molecular species and a potential regulatory role during myoblast differentiation. 2017 J. Biol. Chem. pmid:28275055
Chan RB et al. Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis. 2017 PLoS ONE pmid:28212433
Matsubara T et al. Selective Intracellular Delivery of Ganglioside GM3-Binding Peptide through Caveolae/Raft-Mediated Endocytosis. 2017 Biomacromolecules pmid:28051846
Dam DH et al. Ganglioside GM3 Mediates Glucose-Induced Suppression of IGF-1 Receptor-Rac1 Activation to Inhibit Keratinocyte Motility. 2017 J. Invest. Dermatol. pmid:27729281
Delannoy CP et al. Glycosylation Changes Triggered by the Differentiation of Monocytic THP-1 Cell Line into Macrophages. 2017 J. Proteome Res. pmid:27351377
Hedger G et al. Free Energy Landscape of Lipid Interactions with Regulatory Binding Sites on the Transmembrane Domain of the EGF Receptor. 2016 J Phys Chem B pmid:27109430
Kawashima N et al. Induction of Glycosphingolipid GM3 Expression by Valproic Acid Suppresses Cancer Cell Growth. 2016 J. Biol. Chem. pmid:27539856
Wentworth JM et al. GM3 ganglioside and phosphatidylethanolamine-containing lipids are adipose tissue markers of insulin resistance in obese women. 2016 Int J Obes (Lond) pmid:26499445
Menichella DM et al. Ganglioside GM3 synthase depletion reverses neuropathic pain and small fiber neuropathy in diet-induced diabetic mice. 2016 Mol Pain pmid:27590073
Palomo AG et al. Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it's potential therapeutic implications. 2016 Clin. Exp. Metastasis pmid:27449755
Fedoryszak-Kuśka N et al. Glucosylceramide synthase inhibitors D-PDMP and D-EtDO-P4 decrease the GM3 ganglioside level, differ in their effects on insulin receptor autophosphorylation but increase Akt1 kinase phosphorylation in human hepatoma HepG2 cells. 2016 Acta Biochim. Pol. pmid:27172362
Yoshinaga A et al. NEU3 inhibitory effect of naringin suppresses cancer cell growth by attenuation of EGFR signaling through GM3 ganglioside accumulation. 2016 Eur. J. Pharmacol. pmid:27105818
Winner LK et al. A Preclinical Study Evaluating AAVrh10-Based Gene Therapy for Sanfilippo Syndrome. 2016 Hum. Gene Ther. pmid:26975339
Gentilini MV et al. The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction. 2016 Cancer Immunol. Immunother. pmid:26969612
Gabri MR et al. Racotumomab for treating lung cancer and pediatric refractory malignancies. 2016 Expert Opin Biol Ther pmid:26903265
Wang H et al. Early growth and development impairments in patients with ganglioside GM3 synthase deficiency. 2016 Clin. Genet. pmid:26649472
King B et al. Low-dose, continual enzyme delivery ameliorates some aspects of established brain disease in a mouse model of a childhood-onset neurodegenerative disorder. 2016 Exp. Neurol. pmid:26626972
Xu F et al. Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona Formation. 2016 ACS Nano pmid:26720275
Shorthouse D et al. Molecular simulations of glycolipids: Towards mammalian cell membrane models. 2016 Biochimie pmid:26427555
Murthy RV et al. Exploiting the lactose-GM3 interaction for drug delivery. 2015 ChemMedChem pmid:25801320
Guan F et al. Ganglioside-magnetosome complex formation enhances uptake of gangliosides by cells. 2015 Int J Nanomedicine pmid:26609230
Caughlin S et al. Increased Expression of Simple Ganglioside Species GM2 and GM3 Detected by MALDI Imaging Mass Spectrometry in a Combined Rat Model of Aβ Toxicity and Stroke. 2015 PLoS ONE pmid:26086081
Grey M et al. Acceleration of α-synuclein aggregation by exosomes. 2015 J. Biol. Chem. pmid:25425650
Margheri F et al. Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis. 2015 J. Cell. Mol. Med. pmid:25313007
Miklavcic JJ et al. Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease. 2015 World J. Gastroenterol. pmid:26401073
Lipina C and Hundal HS Ganglioside GM3 as a gatekeeper of obesity-associated insulin resistance: Evidence and mechanisms. 2015 FEBS Lett. pmid:26434718
Saariaho AH et al. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus. 2015 J. Autoimmun. pmid:26227560
Dorvignit D et al. Antitumor and cytotoxic properties of a humanized antibody specific for the GM3(Neu5Gc) ganglioside. 2015 Immunobiology pmid:26224247
Rodriguez-Zhurbenko N et al. Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance. 2015 Ann. N. Y. Acad. Sci. pmid:26214505
Piperno GM et al. Recombinant AAV-mediated in vivo long-term expression and antitumour activity of an anti-ganglioside GM3(Neu5Gc) antibody. 2015 Gene Ther. pmid:26181624
Veillon L et al. Identification of Ganglioside GM3 Molecular Species in Human Serum Associated with Risk Factors of Metabolic Syndrome. 2015 PLoS ONE pmid:26102277
Sugawara Y et al. Clostridium botulinum type C hemagglutinin affects the morphology and viability of cultured mammalian cells via binding to the ganglioside GM3. 2015 FEBS J. pmid:26077172
Dodge JC et al. Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis. 2015 Proc. Natl. Acad. Sci. U.S.A. pmid:26056266
Vukovic I et al. The missing link - likely pathogenetic role of GM3 and other gangliosides in the development of diabetic nephropathy. 2015 Kidney Blood Press. Res. pmid:26043887
Zheng XJ et al. Improvement of the immune efficacy of carbohydrate vaccines by chemical modification on the GM3 antigen. 2015 Org. Biomol. Chem. pmid:25982227
Mozzi A et al. NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels. 2015 Glycobiology pmid:25922362
Randeria PS et al. siRNA-based spherical nucleic acids reverse impaired wound healing in diabetic mice by ganglioside GM3 synthase knockdown. 2015 Proc. Natl. Acad. Sci. U.S.A. pmid:25902507
Yu X et al. Dressing up Nanoparticles: A Membrane Wrap to Induce Formation of the Virological Synapse. 2015 ACS Nano pmid:25853367
DeMarco ML Molecular dynamics simulations of membrane- and protein-bound glycolipids using GLYCAM. 2015 Methods Mol. Biol. pmid:25753721
Yoshikawa M et al. Ganglioside GM3 is essential for the structural integrity and function of cochlear hair cells. 2015 Hum. Mol. Genet. pmid:25652401
Martinez-Martin N et al. Herpes simplex virus enhances chemokine function through modulation of receptor trafficking and oligomerization. 2015 Nat Commun pmid:25625471
Hakomori SI and Handa K GM3 and cancer. 2015 Glycoconj. J. pmid:25613425
Li Y et al. Ganglioside GM3 exerts opposite effects on motility via epidermal growth factor receptor and hepatocyte growth factor receptor-mediated migration signaling. 2015 Mol Med Rep pmid:25503644
Hernández AM and Vázquez AM Racotumomab-alum vaccine for the treatment of non-small-cell lung cancer. 2015 Expert Rev Vaccines pmid:25420897
Torbidoni AV et al. Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 Ganglioside in retinoblastoma tumours. 2015 Acta Ophthalmol pmid:25403557
Nagafuku M et al. Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3. 2015 Glycobiology pmid:25303960
Albohy A et al. Mapping substrate interactions of the human membrane-associated neuraminidase, NEU3, using STD NMR. 2015 Glycobiology pmid:25294388
Kaneko T et al. Histochemical and immunoelectron microscopic analysis of ganglioside GM3 in human kidney. 2015 Clin. Exp. Nephrol. pmid:24985965
Boccuto L et al. A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. 2014 Hum. Mol. Genet. pmid:24026681
Kang S et al. Altered levels of α-synuclein and sphingolipids in Batten disease lymphoblast cells. 2014 Gene pmid:24534465
Li X et al. Activation of Nlrp3 inflammasomes enhances macrophage lipid-deposition and migration: implication of a novel role of inflammasome in atherogenesis. 2014 PLoS ONE pmid:24475307
Willing AE et al. Repeated administrations of human umbilical cord blood cells improve disease outcomes in a mouse model of Sanfilippo syndrome type III B. 2014 Cell Transplant pmid:25565636
Sapra G et al. The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice. 2014 Nat Commun pmid:25489988
Yau YY et al. Bimodal plasma metabolomics strategy identifies novel inflammatory metabolites in inflammatory bowel diseases. 2014 Discov Med pmid:25227752
Giuffrida F et al. Longitudinal evolution of the concentration of gangliosides GM3 and GD3 in human milk. 2014 Lipids pmid:25186772
Yu X et al. Glycosphingolipid-functionalized nanoparticles recapitulate CD169-dependent HIV-1 uptake and trafficking in dendritic cells. 2014 Nat Commun pmid:24947940
Jin UH et al. Ganglioside GM3 is required for caffeic acid phenethyl ester-induced megakaryocytic differentiation of human chronic myelogenous leukemia K562 cells. 2014 Biochem. Cell Biol. pmid:24934090
Gajdosik Z Racotumomab - a novel anti-idiotype monoclonal antibody vaccine for the treatment of cancer. 2014 Drugs Today pmid:24918647
Jaishree G and Sharmila DJ Molecular dynamics study of the conformations of glycosidic linkages in sialic acid modified ganglioside GM3 analogues. 2014 Glycoconj. J. pmid:24909815
Lukina E et al. Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4 years of treatment. 2014 Blood Cells Mol. Dis. pmid:24835462
Chung TW et al. The ganglioside GM3 is associated with cisplatin-induced apoptosis in human colon cancer cells. 2014 PLoS ONE pmid:24829158
Alfonso S et al. A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer patients. 2014 Clin. Cancer Res. pmid:24788102
Huang Q et al. A new liquid chromatography/tandem mass spectrometry method for quantification of gangliosides in human plasma. 2014 Anal. Biochem. pmid:24680754
Lee H et al. Inhibition of GM3 synthase attenuates neuropathology of Niemann-Pick disease Type C. by affecting sphingolipid metabolism. 2014 Mol. Cells pmid:24599001
Qu H et al. Synthesis and cytotoxicity assay of four ganglioside GM3 analogues. 2014 Eur J Med Chem pmid:24534540
Inokuchi J GM3 and diabetes. 2014 Glycoconj. J. pmid:24399479
Wang XQ et al. Ganglioside GM3 depletion reverses impaired wound healing in diabetic mice by activating IGF-1 and insulin receptors. 2014 J. Invest. Dermatol. pmid:24326453
Kim SJ et al. Monosialic ganglioside GM3 specifically suppresses the monocyte adhesion to endothelial cells for inflammation. 2014 Int. J. Biochem. Cell Biol. pmid:24120649
Niimi K et al. Improvement of spontaneous alternation behavior deficit by activation of α4β2 nicotinic acetylcholine receptor signaling in the ganglioside GM3-deficient mice. 2013 Biomed. Res. pmid:23995055
Hidari KI et al. Influenza virus utilizes N-linked sialoglycans as receptors in A549 cells. 2013 Biochem. Biophys. Res. Commun. pmid:23747419
Puryear WB et al. Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169. 2013 PLoS Pathog. pmid:23593001
Richichi B et al. Multivalent presentation of a hydrolytically stable GM(3) lactone mimetic as modulator of melanoma cells motility and adhesion. 2013 Bioorg. Med. Chem. pmid:23583030
Novak A et al. Renal distribution of ganglioside GM3 in rat models of types 1 and 2 diabetes. 2013 J. Physiol. Biochem. pmid:23564406
Casadesús AV et al. A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells. 2013 Glycoconj. J. pmid:23547010
Yan Q et al. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma. 2013 Mol. Cancer Res. pmid:23525268
Huang X et al. Ganglioside GM3 inhibits hepatoma cell motility via down-regulating activity of EGFR and PI3K/AKT signaling pathway. 2013 J. Cell. Biochem. pmid:23355442
Rodríguez-Zhurbenko N et al. Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties. 2013 Eur. J. Immunol. pmid:23319307
Oda M et al. Bacillus cereus sphingomyelinase recognizes ganglioside GM3. 2013 Biochem. Biophys. Res. Commun. pmid:23313504
Inokuchi J et al. Heterogeneity of gangliosides among T cell subsets. 2013 Cell. Mol. Life Sci. pmid:23233133
Scaringi R et al. NEU3 sialidase is activated under hypoxia and protects skeletal muscle cells from apoptosis through the activation of the epidermal growth factor receptor signaling pathway and the hypoxia-inducible factor (HIF)-1α. 2013 J. Biol. Chem. pmid:23209287
Rojas G et al. Engineering the binding site of an antibody against N-glycolyl GM3: from functional mapping to novel anti-ganglioside specificities. 2013 ACS Chem. Biol. pmid:23138862
Wang H et al. Antitumor effects of exogenous ganglioside GM3 on bladder cancer in an orthotopic cancer model. 2013 Urology pmid:23102779
Hayashi N et al. Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody. 2013 Cancer Sci. pmid:23004020
Margheri G et al. Fabrication of GM3-enriched sphingomyelin/cholesterol solid-supported lipid membranes on Au/SiO2 plasmonic substrates. 2013 Lipids pmid:23591593
Fantini J and Yahi N The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside- and cholesterol-binding domains. 2013 Adv. Exp. Med. Biol. pmid:23775688
Nakashita M et al. Attenuation of acetic acid-induced gastric ulcer formation in rats by glucosylceramide synthase inhibitors. 2013 Dig. Dis. Sci. pmid:22918683
Li Y et al. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway. 2013 Int. J. Biochem. Cell Biol. pmid:23968914
Li Y et al. Ganglioside GM3 promotes HGF-stimulated motility of murine hepatoma cell through enhanced phosphorylation of cMet at specific tyrosine sites and PI3K/Akt-mediated migration signaling. 2013 Mol. Cell. Biochem. pmid:23749170
Brands M et al. No difference in glycosphingolipid metabolism and mitochondrial function in glucocorticoid-induced insulin resistance in healthy men. 2013 J. Clin. Endocrinol. Metab. pmid:23386653